Effect of process conditions on particle size and shape in continuous antisolvent crystallisation of lovastatin

Search results

• Finished

  Future Continuous Manufacturing and Advanced Crystallisation Research Hub (CMAC Hub)

  Florence, A. (Principal Investigator), Brown, C. (Co-investigator), Halbert, G. (Co-investigator), Johnston, B. (Co-investigator), Markl, D. (Co-investigator), Nordon, A. (Co-investigator), Price, C. J. (Co-investigator), Sefcik, J. (Co-investigator) & Ter Horst, J. (Co-investigator)

  EPSRC (Engineering and Physical Sciences Research Council)

  1/01/17 → 30/09/24

  Project: Research

  • Tablet 100%
  • Crystallization 74%
  • Crystal 71%
  • Solvent 69%
  • Mefenamic Acid 55%